Genencor International Inc – Wuxi Enzyme Factory as Transferor and Genencor Mauritius Ltd. as Transferee and Genencor (Wuxi) Bio-Products Co., Ltd. AGREEMENT FOR TRANSFER OF EQUITY INTEREST November 30, 2004 (March 14th, 2005)THIS AGREEMENT FOR TRANSFER OF EQUITY INTEREST is made by and among the following Parties after friendly consultation on the basis of principles of equality and mutual benefit:
Genencor International Inc – PROMISSORY NOTE (Repayable/Employee) (March 14th, 2005)FOR VALUE RECEIVED, the undersigned Mark Goldsmith (the “Employee”) and Anne Midler (the “Employee’s Spouse”), promise to pay to the order of GENENCOR INTERNATIONAL, INC. (“Genencor” or the “Company”), Two Hundred Thousand Dollars ($200,000.00) without interest, (except in the event of default, delinquent payment or as otherwise set out below), at the principal offices of Genencor, upon the following terms and conditions:
Genencor International Inc – PUBLIC HEALTH SERVICE PATENT LICENSE AGREEMENT—EXCLUSIVE COVER PAGE (March 14th, 2005)Any related foreign filed national stage applications claiming priority to such patent applications and patents listed in I (a)-(e) above.
Genencor International Inc – CONTRACT GRANTING STATE-OWNED LAND USE RIGHT Wuxi/State Land/Resource/Grant/Contract No. (2005) (March 14th, 2005)The Parties, in accordance with the “Law of the People’s Republic of China on Land Administration (1998), “Law of the People’s Republic of China on Administration of Urban Real Properties (1994), and other applicable laws and regulations implemented by the State and Wuxi City, Jiangsu Province, based on the principle of equality, free will, compensation and integrity, hereby agree to sign this Contract Granting State-Owned Land Use Right.
Genencor International Inc – GENENCOR INTERNATIONAL, INC. VARIABLE PAY PLAN (For Base Periods starting on or after January 1, 2004) (March 14th, 2005)
Genencor International Inc – FOURTH AMENDMENT TO STOCKHOLDER AGREEMENT (February 2nd, 2005)This Fourth Amendment (the “Fourth Amendment”) to the Stockholder Agreement dated July 25, 2000 (together with the First, Second and Third Amendments thereto, the “Stockholder Agreement”), by and among Genencor International, Inc. (the “Company”), Eastman Chemical Company (“Eastman”), and Danisco A/S (together with its applicable affiliates “Danisco”) is dated as of the 27th day of January, 2005.
Genencor International Inc – ACQUISITION AGREEMENT (February 2nd, 2005)THIS AGREEMENT is made and entered into as of January 27, 2005 among DANSICO A/S, a Danish corporation (“Danisco”), DH Subsidiary Inc., a Delaware corporation and an indirect wholly-owned subsidiary of Danisco (the “Buyer”), and GENENCOR INTERNATIONAL, INC., a Delaware corporation (the “Company”).
Genencor International Inc – RESIDENTIAL LEASE (November 8th, 2004)Exhibit 10.3 RESIDENTIAL LEASE 1. PARTIES: This Lease is made and entered into effective this 20th day of August, 2004 ("Commencement Date"), by and between Genencor International, Inc. (hereinafter referred to as "Landlord") and Richard J. Ranieri (individually, "Executive Employee") and Nancy J. Ranieri (hereinafter referred to collectively as "Tenant"). 2. PREMISES: Landlord hereby leases to Tenant and Tenant hereby leases from Landlord, on the terms and conditions hereinafter set forth, that certain real property and the residence located thereon situated in the City of [ ], County of [ ], State of California, commonly known as [residential address]. 3. TERM: The Term of this Lease shall commence on the date Landlord acquires title to the Premises, and end on the sooner to occur of the following: (i) Thirty-six (36) calendar month
Genencor International Inc – 2002 OMNIBUS INCENTIVE PLAN (November 8th, 2004)Exhibit 10.1 AWARD NOTICE NOTICE OF NONQUALIFIED STOCK OPTION GRANTED PURSUANT TO THE GENENCOR INTERNATIONAL, INC. 2002 OMNIBUS INCENTIVE PLAN Grantee: ------------------------------------------------- Number of Shares: ---------------------------------------- Option Price: $ ------------------------------------------ Date of Grant: ------------------------------------------- 1. GRANT OF OPTION. This Award Notice serves to notify you that the Management Development and Compensation Committee (the "Committee") of the Board of Directors of Genencor International, Inc. (the "Company") has granted to you, under the Company's 2002 Omnibus Incentive Plan (the "Plan"), a nonqualified stock option (the "Option") to purchase, on
Genencor International Inc – RESIDENTIAL LEASE (November 8th, 2004)Exhibit 10.2 RESIDENTIAL LEASE 1. PARTIES: This Lease is made and entered into effective this 20th day of August, 2004 ("Commencement Date"), by and between Genencor International, Inc. (hereinafter referred to as "Landlord") and Raymond J. Land (individually, "Executive Employee") and Kathleen A. Land (hereinafter referred to collectively as "Tenant"). 2. PREMISES: Landlord hereby leases to Tenant and Tenant hereby leases from Landlord, on the terms and conditions hereinafter set forth, that certain real property and the residence located thereon situated in the City of [ ], County of [ ], State of California, commonly known as [residential address]. 3. TERM: The Term of this Lease shall commence on the date Landlord acquires title to the Premises, and end on the sooner to occur of the following: (i) Thirty-six (36) calendar months f
Genencor International Inc – RENTAL AGREEMENT (August 6th, 2004)EXHIBIT 10.5 RENTAL AGREEMENT In accordance with chapter 5 of the Tenancy Act, dated April 29, 1966, the city of Hanko is hereby renting, to a corporation named Suomen Sokeri Osakeyhtio from the city of Helsinki, which below will be referred to as "the company", the property Nynorrgard RNo 7:20, owned by the city of Hanko, within the city of Hanko and the subdivision of Hanko, the below-mentioned area for use as an industrial facility, based on the following terms and conditions. 1 The size of the area to be rented is 121,600 m(2) and is marked on the map with a blue line, and it is also delineated with poles in the terrain. For a period of 15 years, the city promises to reserve, and within the same period to rent to the company with separately agreed terms and conditions, an additional area of the size of approximately 150,000 m(2), which is marked on the map with a red line, and which is to be used for industri
Genencor International Inc – EMPLOYMENT AGREEMENT (August 6th, 2004)EXHIBIT 10.3 EMPLOYMENT AGREEMENT THIS AGREEMENT made as of the date last written below by and between Genencor International, Inc. ("GCOR"), a Delaware Corporation with a principal office at 925 Page Mill Road, Palo Alto, California 94304-1013 and Jean-Jacques Bienaime ("Employee"), residing at 500 Kingsley Ave, Palo Alto, CA 94301. WHEREAS, GCOR desires to employ the Employee and the Employee desires to work for GCOR, and GCOR and the Employee desire to define the terms and conditions under which GCOR will employ the Employee. NOW, THEREFORE, the parties hereby covenant and agree as follows: 1. GCOR hereby employs the Employee as Chairman and Chief Executive Officer to perform such duties consistent with his title and position as may be determined and assigned to him by the Board of Directors of GCOR. 2. The Employee agrees to devote substantia
Genencor International Inc – EMPLOYMENT AND SEPARATION AGREEMENT (August 6th, 2004)EXHIBIT 10.2 EMPLOYMENT AND SEPARATION AGREEMENT This Employment and Separation Agreement (the "Agreement") is entered into by and between Stuart L. Melton ("Executive") and Genencor International, Inc. (the "Company" or"GCOR") effective as of the date set forth in Paragraph 12 herein. WHEREAS, Executive has served as an executive officer of GCOR in the position of General Counsel and Secretary since the Company's inception in 1990; WHEREAS, on April 15, 2004, Executive and GCOR entered into an Employment Agreement, a copy of which is attached hereto as Attachment A and incorporated herein by reference (the "Original Employment Agreement"); WHEREAS, Executive desires to resign from his current position and GCOR desires to continue to benefit from Executive's experience during a transition period of employment through December 31, 2004. NOW, THEREFORE, in cons
Genencor International Inc – AMENDED AND RESTATED RESEARCH AGREEMENT (August 6th, 2004)EXHIBIT 10.1 *** TEXT OMITTED AND FILED SEPARATELY CONFIDENTIAL TREATMENT REQUESTED AMENDED AND RESTATED RESEARCH AGREEMENT This Amended and Restated Research Agreement (the "Agreement") is made this 14th day of June, 2004 and effective on January 1, 2004 (the "Effective Date") by and between DOW CORNING CORPORATION having a principal place of business at 2200 Salzburg Road, P.O. Box 994 Midland, Michigan 48686-0994 ("DCC") and GENENCOR INTERNATIONAL, INC. having a principal place of business at 925 Page Mill Road, Palo Alto, CA 94304-1013 ("GCOR") (collectively referred to herein as the "Parties") WHEREAS, the Parties signed a certain Memorandum of Understanding dated [ *** ] (the "MOU") whereby the Parties intended to form a pre-eminent alliance in the Field of Silicon Biotechnology a
Genencor International Inc – EMPLOYMENT AGREEMENT (August 6th, 2004)EXHIBIT 10.4 EMPLOYMENT AGREEMENT THIS AGREEMENT made as of the date last written below by and between Genencor International, Inc. ("GCOR"), a Delaware Corporation with a principal office at ____________________ and _______________ ("Employee"), residing at ____________________. WHEREAS, GCOR desires to employ the Employee and the Employee desires to work for GCOR, and GCOR and the Employee desire to define the terms and conditions under which GCOR will employ the Employee. NOW, THEREFORE, the parties hereby covenant and agree as follows: 1. GCOR hereby employs the Employee as ____________________ to perform such duties consistent with his title and position as may be determined and assigned to him by the Chief Executive Officer or Board of Directors of GCOR. 2. The Employee agrees to devote substantially all of his professional employment time
Genencor International Inc – NONQUALIFIED DEFERRED COMPENSATION PLAN (March 12th, 2004)Exhibit 10.35 GENENCOR INTERNATIONAL, INC. NONQUALIFIED DEFERRED COMPENSATION PLAN Effective as of September 15, 2003 TABLE OF CONTENTS ARTICLE 1 PURPOSE AND TERM 1.1 Purpose............................................................. 1 1.2 Effective Date...................................................... 1 ARTICLE 2 DEFINITIONS 2.1 "Account"........................................................... 1 2.2 "Additional Shares"................................................. 1 2.3 "Additional Shares Contribution".................................... 1 2.4 "Benef
Genencor International Inc – THIRD AMENDMENT TO STOCKHOLDER AGREEMENT (March 12th, 2004)Exhibit 10.4 THIRD AMENDMENT TO STOCKHOLDER AGREEMENT This Third Amendment (the "Third Amendment") to the Stockholder Agreement dated July 25, 2000 (together with the First and Second Amendments thereto, the "Stockholder Agreement"), by and among Genencor International, Inc. ("Company"), Eastman Chemical Company (together with its applicable affiliates "Eastman"), and Danisco A/S (together with its applicable affiliates "Danisco") is dated as of the 2nd day of April, 2003 and the provisions of this Third Amendment shall be effective as of the date set forth herein. RECITALS The Parties may desire to decrease the total members of directors on the Board of Directors of the Company without otherwise disturbing the rights of the Parties currently enjoyed under the Stockholder Agreement. Therefore, the Parties have agreed to enter into this Thir
Genencor International Inc – CREDIT AGREEMENT (March 12th, 2004)Exhibit 4.10 ================================================================================ [ABN-AMRO LOGO] $40,000,000 THREE YEAR CREDIT AGREEMENT DATED AS OF DECEMBER 23, 2003 BY AND AMONG GENENCOR INTERNATIONAL, INC., THE LENDERS PARTY HERETO AND ABN AMRO BANK, N.V., AS ADMINISTRATIVE AGENT ------------------------------- ABN AMRO INC., AS ADVISOR, BOOK MANAGER AND LEAD ARRANGER =================================================================
Genencor International Inc – TECHNOLOGY TRANSFER AGREEMENT (August 13th, 2003)EXHIBIT 10.2 FIRST AMENDMENT --------------- TO -- RESEARCH AGREEMENT ------------------ AND --- TECHNOLOGY TRANSFER AGREEMENT ----------------------------- This First Amendment to Research Agreement and Technology Transfer Agreement is made and entered into as of June 23, 2003 by and between GENENCOR INTERNATIONAL, INC. (together with its Affiliates, "GCOR") and THE PROCTER & GAMBLE COMPANY (together with its Affiliates, "P&G"), (hereinafter referred to as "the Parties"). A. GCOR and P&G (the "Parties") entered into: (i) a Research Agreement effective June 30, 2000 t
Genencor International Inc – FIRST AMENDMENT TO SUPPLY AGREEMENT (August 13th, 2003)***TEXT OMITTED AND FILED SEPARATELY CONFIDENTIAL TREATMENT REQUESTED EXHIBIT 10.1 FIRST AMENDMENT TO SUPPLY AGREEMENT ----------------------------------- This First Amendment to the Supply Agreement (the "Agreement") is made and entered into as of January 1, 2003 ("Effective Amendment Date") by and between The Procter & Gamble Company (and its affiliates named in the Agreement, collectively "Buyer") and Genencor International, Inc. (with its affiliates, collectively "Seller"). A. Buyer and Seller entered into the Agreement effective October 17, 2001, with respect to the supply by Seller of all Materials to the Buyer. B. The Parties desire to modify the Agreement for [...***...] and [...***...] by including the revised terms below. NOW, THEREFORE, in con
Genencor International Inc – LEASE (May 14th, 2003)EXHIBIT 10.1 LEASE THIS LEASE is made and entered into as of January 30, 2003 (the "EFFECTIVE DATE") by and between THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, a body having corporate powers under the laws of the State of California ("LANDLORD"), and GENENCOR INTERNATIONAL INC., a corporation ("TENANT"). 1. BASIC LEASE INFORMATION The following is a summary of basic lease information. Each term or item in this Article 1 shall be deemed to incorporate all of the provisions set forth below pertaining to such term or item and to the extent there is any conflict between the provisions of this Article 1 and any more specific provision of this Lease, the more specific provision shall control. Landlord: The Board of Trustees of the Leland Stanford Junior Univers
Genencor International Inc – PRIME CONTRACT NO.DE-AC36-99GO10337 (March 26th, 2003)EXHIBIT 10.26 DEFINITIZED SUBCONTRACT NO. ZCO-0-30017-01 UNDER PRIME CONTRACT NO.DE-AC36-99GO10337 CONTRACTING PARTY: MIDWEST RESEARCH INSTITUTE NATIONAL RENEWABLE ENERGY LABORATORY DIVISION SUBCONTRACTOR: GENENCOR INTERNATIONAL, INC. ADDRESS: 925 PAGE MILL ROAD PALO ALTO, CA 94304 SUBCONTRACT TITLE: "CELLULASE COST REDUCTION FOR BIOETHANOL" TYPE OF SUBCONTRACT: COST SHARING PERIOD OF PERFORMANCE: 04/27/00 THROUGH 06/26/03 SUBCONTRACT AMOUNT: SUBCONTRACTORS NREL'S COST SHARE COST SHARE TOTAL -------------- -------------- -------------- $3,388,451.00 $13,553,804.00 $16,942,255.00 (20%) (80%) (100%) PAYME
Genencor International Inc – SECOND AMENDMENT TO LEASE AGREEMENT AND LANDLORD CONSENT (March 26th, 2003)EXHIBIT 10.11 Page 1 SECOND AMENDMENT TO LEASE AGREEMENT AND LANDLORD CONSENT THIS SECOND AMENDMENT TO LEASE AGREEMENT AND LANDLORD CONSENT (the "Second Amendment") is made as of the 8th day of July, 2002, by and between EASTMAN KODAK COMPANY, a New Jersey corporation (hereinafter called "Landlord") and GENENCOR INTERNATIONAL, INC., a Delaware corporation (hereinafter called "Tenant"). WITNESSETH: WHEREAS, by a certain Lease Agreement dated as of August 28, 1991, as amended November 30, 2001 (the "Lease"), Landlord leased to Tenant and Tenant leased from Landlord all that certain parcel of and and improvements, buildings (but not equipment or other personalty acquired by separate bill of sale from Landlord) in the Town of Greece and City of Rochester, County of Monroe, State of New York, as more particularly defined in the Lease and Exhibit A thereto (t
Genencor International Inc – AMENDMENT NO. 4 TO NOTE AGREEMENT (March 26th, 2003)EXHIBIT 4.8 GENENCOR INTERNATIONAL, INC. AMENDMENT NO. 4 TO NOTE AGREEMENT As of October 1, 2000 TO EACH OF THE CURRENT NOTEHOLDERS NAMED IN ANNEX 1 HERETO Ladies and Gentlemen: Genencor International, Inc. (hereinafter, the "Company"), together with its successors and assigns, agrees with you as follows: 1. PRELIMINARY STATEMENTS. 1.1 VOTE ISSUANCE, ETC. The Company issued and sold S140,000,000 aggregate principal amount of its 6.82% Senior Notes due March 30, 2006 (as may be amended, restated or otherwise modified from time to time, the "NOTES") pursuant to a Note Agreement dated March 28, 1996 and entered into by and among the Company and each of the Purchasers listed in Annex 1 attached thereto (as amended by previously executed Amendment Agreements including Amendment No. 3 to Not
Genencor International Inc – FIRST AMENDMENT TO LEASE (March 26th, 2003)EXHIBIT 10.10 FIRST AMENDMENT TO LEASE THIS FIRST AMENDMENT TO LEASE is made as of this 30th day of November, 2001 by and between EASTMAN KODAK COMPANY, a New Jersey corporation having an office at 343 State Street, Rochester, New York 14650 (hereinafter referred to as "Landlord") and GENENCOR INTERNATIONAL, INC., a Delaware corporation having an office at 1700 Lexington Avenue, Rochester, New York 14606 (hereinafter referred to as "Tenant") and amends that certain Lease dated as of August 28, 1991 (the "Lease") by and between Landlord and Tenant. WITNESSETH: WHEREAS, Landlord and Tenant now desire to modify the Lease with respect to the providing of certain services from Landlord to Tenant and the payment of certain sums from Tenant to Landlord; and WHEREAS, capitalized terms used but not otherwise described herein shall hav
Genencor International Inc – SECOND AMENDMENT TO STOCKHOLDER AGREEMENT (March 26th, 2003)EXHIBIT 10.3 SECOND AMENDMENT TO STOCKHOLDER AGREEMENT This Second Amendment (the "Second Amendment") to the Stockholder Agreement dated July 25, 2000 (together with the First Amendment thereto, the "Stockholder Agreement"), by and among Genencor International, Inc. ("Company"), Eastman Chemical Company (together with its applicable affiliates "Eastman"), and Danisco A/S (together with its applicable affiliates "Danisco") is dated the 15th day of November, 2002 and the provisions of this Second Amendment shall be effective as of the date set forth herein. RECITALS The Parties may desire to expand the total members of directors on the Board of Directors of the Company without otherwise disturbing the rights of the Parties currently enjoyed under the Stockholder Agreement. Therefore, the Parties have agreed to enter into this Second Amendment
Genencor International Inc – LICENSE AGREEMENT (March 26th, 2003)EXHIBIT 10.29 FIRST AMENDMENT OF THE LICENSE AGREEMENT This First Amendment (this "FIRST AMENDMENT") to the License Agreement is made and entered into as of October 16, 2002 by and between EPIMMUNE INC., having a principal place of business at 5820 Nancy Ridge Drive, San Diego, CA 92121 ("EPMN"), and GENENCOR INTERNATIONAL, INC., having a principal place of business at 925 Page Mill Road, Palo Alto, CA 94304-1013 ("GCOR") (collectively referred to herein as the "PARTIES") agree as follows: WHEREAS, the Parties have entered into that certain License Agreement dated July 9, 2001 (the "LICENSE AGREEMENT"); and WHEREAS, the Parties wish to amend the License Agreement on the terms and conditions set forth herein; NOW, THEREFORE, in consideration of the mutual undertakings of the Parties as set forth below as well as other
Genencor International Inc – ARTICLES OF ASSOCIATION (March 26th, 2003)EXHIBIT 10.16 AGREEMENT FOR THE FIRST AMENDMENT TO THE AMENDED AND RESTATED EQUITY JOINT VENTURE CONTRACT AND FIRST AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF ASSOCIATION THIS AGREEMENT FOR THE FIRST AMENDMENT TO THE AMENDED AND RESTATED EQUITY JOINT VENTURE CONTRACT AND FIRST AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF ASSOCIATION (the "Agreement for the First Amendment"), dated as of December 23, 2002, is entered into by and between Wuxi Enzymes Factory ("Party A"), a state-owned enterprise registered and existing under the laws of the People's Republic of China (the "PRC"), and Genencor Mauritius Ltd. ("Party B"), a limited liability company organized and existing under the laws of the Republic of Mauritius (each a "Party", and together the "Parties"). WHEREAS, pursuant to that certain Amended and Restated Eq
Genencor International Inc – EMPLOYMENT AGREEMENT (March 26th, 2003)EXHIBIT 10.20 EMPLOYMENT AGREEMENT THIS AGREEMENT made as of the date last written below by and between Genencor International, Inc. ("GCOR"), a Delaware Corporation with a principal office at 925 Page Mill Road, Palo Alto, California 94104-1013 and Jean Jacques Bienaime ("Employee"), residing at 500 Kingsley Avenue, Palo Alto, California 94301. WHEREAS, GCOR desires to employ the Employee and the Employee desires to work for GCOR, and GCOR and the Employee desire to define the terms and conditions under which GCOR will employ the Employee. NOW, THEREFORE, the parties hereby covenant and agree as follows: 1. GCOR agrees to employ the Employee as Chief Executive Officer (CEO) and President upon appointment to those offices by GCOR's Board of Directors (the "Board") on or about November 15, 2002 to perform such duties consistent with his title
Genencor International Inc – FIRST AMENDMENT TO STOCKHOLDER AGREEMENT (March 26th, 2003)EXHIBIT 10.2 FIRST AMENDMENT TO STOCKHOLDER AGREEMENT This First Amendment (the "First Amendment") to the Stockholder Agreement dated July 25, 2000 ("Stockholder Agreement"), by and among Genencor International, Inc. ("Company"), Eastman Chemical Company ("Eastman"), and Danisco A/S ("Danisco") is dated the 16th day of February, 2001 and the provisions of this First Amendment shall be effective as of the date set forth herein. RECITALS Eastman and Danisco may desire to expand their rights to manage certain assets, including their rights in the Company, by transfer of those shares to a wholly owned subsidiary of their respective companies, and without otherwise disturbing the rights of the Parties in the Stockholder Agreement. Therefore, the Parties have agreed to enter into this First Amendment to achieve the foregoing objectives.
Genencor International Inc – COLLABORATION AGREEMENT (March 26th, 2003)*** TEXT OMITTED AND FILED SEPARATELY CONFIDENTIAL TREATMENT REQUESTED EXHIBIT 10.31 FIRST AMENDMENT OF THE COLLABORATION AGREEMENT This First Amendment (this "FIRST AMENDMENT") to the Collaboration Agreement is made and entered into as of October 16, 2002 by and between EPIMMUNE INC., having a principal place of business at 5820 Nancy Ridge Drive, San Diego, CA 92121 ("EPMN"), and GENENCOR INTERNATIONAL, INC., having a principal place of business at 925 Page Mill Road, Palo Alto, CA 94304-1013 ("GCOR") (collectively referred to herein as the "PARTIES") agree as follows: WHEREAS, the Parties have entered into that certain Collaboration Agreement dated July 9, 2001 (the "COLLABORATION AGREEMENT"); and WHEREAS, the Parties wish to amend the C
Genencor International Inc – NOTE AGREEMENT (March 26th, 2003)EXHIBIT 4.6 AMENDMENT NO. 2 TO NOTE AGREEMENT This AMENDMENT NO. 2 TO NOTE AGREEMENT (this "Amendment"), dated as of December 31, 1996, is made by and among GENENCOR INTERNATIONAL, INC., a Delaware corporation (together with its successors and assigns, the "Company"), and each of the institutions that are signatories hereto (such institutions being collectively referred to as the "Noteholders"). BACKGROUND 1. The Company and each of the Noteholders are parties to the Note Agreement dated as of March 28, 1996, as amended by Amendment No. 1 to Note Agreement dated as of September 25, 1996 (as so amended prior to the effectiveness of this Amendment, the "Existing Note Agreement" and as amended by this Amendment, the "Amended Note Agreement"), pursuant to which the Co
Genencor International Inc – AMENDMENT NO. 5 TO NOTE AGREEMENT (March 26th, 2003)EXHIBIT 4.9 GENENCOR INTERNATIONAL, INC. AMENDMENT NO. 5 TO NOTE AGREEMENT As of April 17, 2002 TO EACH OF THE CURRENT NOTEHOLDERS NAMED IN ANNEX 1 HERETO Ladies and Gentlemen: GENENCOR INTERNATIONAL, INC. (hereinafter, the "COMPANY"), together with its successors and assigns, agrees with you as follows: 1. PRELIMINARY STATEMENTS 1.1 NOTE ISSUANCE, ETC. The Company issued and sold S140,000,000 aggregate principal amount of its 6.82% Senior Notes due March 30, 2006 (as may be amended, restated or otherwise modified from time to time, the "NOTES") pursuant to a Note Agreement dated March 28, 1996 and entered into by and among the Company and each of the Purchasers listed in Annex 1 attached thereto (as amended by previously executed Amendment Agreements including Amendment No. 4
Genencor International Inc – AMENDMENT NO. 3 TO NOTE AGREEMENT (March 26th, 2003)EXHIBIT 4.7 GENENCOR INTERNATIONAL, INC. AMENDMENT NO. 3 TO NOTE AGREEMENT As of May 5, 2000 TO EACH OF THE CURRENT NOTEHOLDERS NAMED IN ANNEX 1 HERETO: Ladies and Gentlemen: GENENCOR INTERNATIONAL, INC. (hereinafter, the "COMPANY"), together with its successors and assigns, agrees with you as follows: 1. PRELIMINARY STATEMENTS. 1.1 NOTE ISSUANCE, ETC. The Company issued and sold $140,000,000 aggregate principal amount of its 6.82% Senior Notes due March 30, 2006 (as may be amended, restated or otherwise modified from time to time, the "NOTES") pursuant to a Note Agreement dated March 30, 1996 (as in effect immediately prior to giving effect to the Amendments provided for by this Amendment Agreement, the "EXISTING NOTE AGREEMENT"). The register for the registration and transfer o
Genencor International Inc – NOTE AGREEMENT (March 26th, 2003)EXHIBIT 4.5 AMENDMENT NO. 1 TO NOTE AGREEMENT This AMENDMENT NO. 1 TO NOTE AGREEMENT (this "Amendment"), dated as of September 25, 1996, is made by and among GENENCOR INTERNATIONAL, INC., a Delaware corporation (together with its successors and assigns, the "Company"), and each of the institutions that are signatories hereto (such institutions being collectively referred to as the "Noteholders"). BACKGROUND 1. The Company and each of the Noteholders are parties to the Note Agreement (the "Existing Note Agreement"), dated as of March 28, 1996, that provides, among other things, for the sale by the Company and the purchase by the Noteholders of One Hundred Forty Million Dollars ($140,000,000) in aggregate principal amount of the Company's 6.82% Senior Notes due Marc
